From August 1, 2022 to October 31, 2022, the company has repurchased 2,023,515 shares, representing 9.75% for $5.58 million. With this, the company has completed the repurchase of 2,875,496 shares, representing 13.86% for $7.65 million under the buyback announced on June 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | +0.47% | -4.50% | -1.85% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.85% | 17.92M | |
+26.47% | 664B | |
+25.70% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.42% | 234B | |
+4.71% | 199B | |
-10.10% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on June 2, 2022.